This information is intended for Canadian residents.

Sanofi is a leader in the global pharmaceutical market, with an extensive line of prescription medicines. Links to comprehensive information about our pharmaceutical products are listed below, most frequently in the form of a product monograph.

This information has been approved by Health Canada and should be read and discussed in consultation with a health care professional.

Adlyxine®

(lixisenatide injection)

Admelog™ and Admelog™
SoloSTAR®

(insulin lispro injection)

Aldurazyme®

(laronidase)

AllStar® Pro

Alprolix®

(coagulation factor IX (recombinant), Fc fusion protein)

Apidra®

(insulin glulisine)

Arava®

(leflunomide)

Aubagio®

(teriflunomide)

Avalide®

(irbesartan, hydrochlorothiazide)

Avapro®

(irbesartan)

Buscopan®

(hyoscine butylbromide)

Cablivi™

(caplacizumab)

Calcimar®

(calcitonin-salmon)

Caprelsa®

(vandetanib)

Cerdelga®

(eliglustat)

Cerezyme®

(imiglucerase)

Clolar®

(clofarabine for injection)

Cyclomen®

(danazol)

Dupixent®

(dupilumab)

Eloctate®

(antihemophilic factor (recombinant BDD), Fc fusion protein )

Fabrazyme®

(agalsidase beta)

Fasturtec®

(rasburicase)

Ferrlecit®

(sodium ferric gluconate)

Flagyl®

(metronidazole)

Flagystatin®

(metronidazole, nystatin)

Fludara®

(fludarabine phosphate)

Glucophage®  

Trademark of Merck Santé s.a.s. Commercialized in Canada by sanofi-aventis. (metformin hydrochloride)

Imovane®

(zopiclone)

Jevtana®

(cabazitaxel)

JuniorSTAR®

Kayexalate®

(sodium polystyrene sulfonate)

Kevzara®

(sarilumab)

Lantus®

(insuline glargine)

For more information, contact Sanofi Canada at 1-888-852-6887

Lasix® Oral Solution

(furosemide)

Lasix® Special

(furosemide)

Lemtrada®

(alemtuzumab)

Libtayo™

(cemiplimab)

Lovenox® /
Lovenox® HP

(enoxaparin sodium)

MabCampath®

(alemtuzumab)

Mozobil®

(plerixafor injection)

Multaq®

(dronedarone tablets)

Myozyme®

(alglucosidase alfa)

Nalcrom®

(sodium cromoglycate)

Nasacort® AQ

(triamcinolone acetonide)

NexviazymeTM

(avalglucosidase alfa for injection)

Nitrolingual® Pumpspray

Trademark of G. Pohl-Boskamp GmbH & Co. Commercialized in Canada by sanofi-aventis. (nitroglycerin)

Nozinan®

(methotrimeprazine)

Pediapred®

(prednisolone sodium phosphate)

Plaquenil®

(hydroxychloroquine sulfate)

Plavix®

(clopidogrel bisulfate)

Praluent®

(alirocumab)

Primaquine®

(primaquine phosphate)

Renagel®

(sevelamer hydrochloride tablets)

Renvela®

(sevelamer carbonate tablets)

Resonium® Calcium

(calcium polystyrene sulfonate)

Rezurock®

(belumosudil)

Rilutek®

(riluzole)

Sarclisa™

(isatuximab for injection)

Sofracort®

(framycetin sulphate, gramicidin, dexamethasone)

Soliqua®

(insulin glargine and lixisenatide for injection)

Synvisc® /Synvisc-One®

(hylan G-F 20)

Thymoglobulin®

(anti-thymocyte globulin)

Thyrogen®

(thyrotropin alpha)

Toujeo® SoloSTAR® Toujeo®
DoubleSTAR®

(insulin glargine)

Trurapi™

(insulin aspart injection)

Xatral®

(alfuzosin hydrochloride)

Zaroxolyn®

(metolazone)